Measuring the cost of a pediatric vaccine administration in the UK

S Mokiou1, B Standaert2, X Li2

  • 1Merck UK & ROI, Merck Serono Ltd, Feltham, Middlesex, UK.

Vaccine
|December 7, 2017
PubMed

Insights

This study accurately calculated the time and cost for vaccine administration in UK pediatric practices. The total cost per vaccine visit, including all activities, was £11.9.

Area of Science:

  • Health economics
  • Vaccinology
  • Public health

Background:

  • Vaccine administration costs are often underestimated due to incomplete reporting of pre-vaccination and on-the-day activities.
  • Accurate cost-effectiveness analysis is crucial for healthcare resource allocation and policy-making.

Purpose of the Study:

  • To accurately determine the total time and cost associated with vaccine dose administration in UK general practitioner (GP) practices.
  • To provide a comprehensive cost analysis that includes all activities from preparation to post-vaccination.

Main Methods:

  • A field study was conducted across 6 UK GP sites over 4 months (April-June 2015).
  • Workflow mapping and interviews were used to identify pre-vaccination activities and estimate their costs.
  • Time & Motion (T&M) methodology was employed for a prospective, non-interventional study to measure on-the-day vaccination activities, including consumables and guardian time.
  • Data were analyzed using a random intercept model to account for site-specific variations.

Main Results:

  • 123 T&M observations were collected, stratified by vaccination visit within the first year of life.
  • The total cost per vaccine visit, including supply costs and pre-vaccination activities, averaged £11.9 (range: £8.6-£17.0).
  • The time per vaccine dose administered was 7.1 minutes (range: 5.7-9.2), with an associated cost of £4.3 (range: £3.1-£6.2).

Conclusions:

  • The study provides an accurate reflection of the resources required for vaccine administration in UK pediatric settings.
  • The calculated costs align with the current National Health Services (NHS) fee schedule, validating the methodology.
  • This detailed cost analysis can inform healthcare budgeting and improve the efficiency of vaccination programs.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...